/

Società

AM

Non verificato

AMRA Medical

Di cosa scriviamo

AccessoriFitnessMultimedialitàSaluteVetrine/Shopping

9 comunicati stampa

Guarda tutti i comunicati

18/09/2025

Setting the Standard: AMRA Medical Recognized as one of TIME Magazine’s ‘World’s Top HealthTech Companies’

Fonte

Emittente

1.00

0

01/05/2025

Latest Data from SURPASS-3 Trial Gleans Insight Into the Association of Tirzepatide Treatment with Changes in Muscle Composition in Type 2 Diabetes

Fonte

Emittente

1.00

0

15/04/2025

Decoding Duchenne Muscular Dystrophy: MRI Study Explores the Relationship Between AMRA’s Muscle Biomarkers and Functional Changes in Individuals With DMD

Fonte

Emittente

1.00

0

24/10/2024

Latest AMRA Medical Research in Muscle & Nerve Demonstrates The Utility of MRI-based Biomarkers In Inflammatory Myopathies

Fonte

Emittente

1.00

0

23/10/2024

AMRA® Profiler 4 Pilot Study Demonstrates Feasible Assessment of Muscle Composition in Liver Transplant Candidates

Fonte

Emittente

1.00

0

22/10/2024

New AMRA Medical Study Published in Obesity Links Antidepressant Use with Poor Muscle Health and Increased Cardiometabolic Risk

Fonte

Emittente

1.00

0

16/10/2024

Adapting To Change: New Focused Review in Circulation Explores The Relationship Between Weight Reduction and Muscle Health

Fonte

Emittente

1.00

0

29/08/2024

AMRA Medical Secures European Medical Device Regulation Certificate for AMRA® Profiler 4, Highlighting Yet Another Regulatory Win

Fonte

Emittente

1.00

0

25/04/2024

Accessori

Vetrine/Shopping

Salute

Fitness

Formazione professionale

Scuola/Istruzione

Medicina - Varie

Scienza

Multimedialità

Baseline Enrollment Completed for AMRA Medical and Linköping University’s Landmark Liver Disease Study

Fonte

Emittente

1.00

0

Seguaci

0

Compatibilità

0